Select patient characteristics for patients with cirrhosis admitted to the inpatient hepatology service, by preintervention and postintervention groups
| Characteristic | Preintervention | Postintervention |
| Age (median), IQR | 58 (48, 65) | 58 (48, 64) |
| Sex (F), n (%) | 71 (38.0) | 73 (37.6) |
| Race, n (%) | ||
| White | 141 (75.4) | 140 (72.2) |
| Black/African American | 16 (8.6) | 13 (7.3) |
| Hispanic | 10 (5.3) | 11 (5.7) |
| Asian | 5 (2.7) | 6 (3.4) |
| Primary care visit within 2 years of admission, n (%) | 24 (12.9) | 25 (12.9) |
| Have outpatient Gastrointestinal doctor, n (%) | 158 (89.8) | 179 (93.2) |
| Cause of cirrhosis, n (%) | ||
| Alcohol | 107 (57.2) | 115 (59.3) |
| Non-alcoholic steatohepatitis (NASH) | 39 (20.9) | 33 (17.0) |
| Autoimmune | 7 (3.7) | 7 (3.6) |
| HCV | 35 (18.7) | 36 (18.6) |
| Other | 30 (16.0) | 35 (18.0) |
| Unknown | 7 (3.7) | 0 |
| MELD-Na† (median), IQR | 21 (15, 26) | 20 (15, 27) |
| Length of stay in days (median), IQR | 6 (3, 13) | 5 (3, 10) |
| Immune to hepatitis A*, n (%)* | 27 (48.2) | 23 (46.9) |
*Percentage is based on the subset of patients whose serologies were checked.
†Model for Endstage Liver disease: prognostic scoring system for liver cirrhosis incorporating renal function, bilirubin, INR, and sodium
HCV, hepatitis C virus.